InvestorsHub Logo
Followers 77
Posts 2522
Boards Moderated 1
Alias Born 12/04/2020

Re: bme post# 88951

Saturday, 09/04/2021 4:29:17 PM

Saturday, September 04, 2021 4:29:17 PM

Post# of 118384
If Koos gets a reasonable offer, he will sell. RGBP is cash poor and doesn't have the research or clinical team currently to push forward with clinical trials. Selling is their best option. They just can't give it away, though. I think a buyout has to be for at least $7 billion. And that's absolute minimum.

JACK'S RULES OF TRADING
1. Never chase a stock that's already run up considerably.
2. Never panic sell. In other words: When in doubt, hold.
3. When the stock price is down but the company still has potential, add.